Xia Meng
Fudan University(CN)Daqing Oilfield General Hospital(CN)China National Petroleum Corporation (China)(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, RNA Interference and Gene Delivery, Immunotherapy and Immune Responses, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19(2020)1,181 cited
- → In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19(2020)498 cited
- → Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes(2020)165 cited
- → Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19(2020)153 cited
- → Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies(2016)137 cited
- → Novel Gold Nanorod-Based HR1 Peptide Inhibitor for Middle East Respiratory Syndrome Coronavirus(2019)95 cited